Retraction Note: Construction of pancreatic cancer double-factor regulatory network based on chip data on the transcriptional level [Mol Biol Rep, (2014), 41, (2875-2883), DOI 10.1007/s11033-014-3143-4];Construction of pancreatic cancer double-factor regulatory network based on chip data on the transcriptional level

Molecular Biology Reports

Volumn 41, Issue 5, 2014, Pages 2875-2883

  Zhao, Li Li ^a   Zhang, Tong ^a   Liu, Bing Rong ^a   Liu, Tie Fu ^a   Tao, Na ^a   Zhuang, Li Wei ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Differentially expressed genes (DEGs); MicroRNA (miRNA); Pancreatic cancer; Transcription factor (TF)

Indexed keywords

MICRORNA; PROTEIN BRIP1; PROTEIN LAMC2; PROTEIN MIR155; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; GENE CONSTRUCT; GENE MAPPING; GENE REGULATORY NETWORK; GENETIC DATABASE; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR MECHANICS; PANCREAS CANCER; PROTEIN ANALYSIS; TRANSCRIPTION REGULATION; BIOLOGY; CASE CONTROL STUDY; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PANCREAS TUMOR; PROCEDURES; REGULATORY SEQUENCE;

CASE-CONTROL STUDIES; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; PANCREATIC NEOPLASMS; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84905686247     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-015-3886-6     Document Type: Erratum

References (35)

1. Ekbom A, Mclaughlin JK, Nyren O (1993) Pancreatitis and the risk of pancreatic cancer. N Engl J Med 329:1502-1503
2. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, Dimagno EP, Andren-Sandberg A, Domellof L (1993) Pancreatitis and the risk of pancreatic cancer. N Engl J Med 328:1433-1437 (Pubitemid 23143844)
3. Edwards LE and John Pojeta J, Fossils, Rocks, and Time, U.S.D.o.t. Interior, Editor. 1997, U.S. Geological Survey
4. Wu SF, Qian WY, Zhang JW, Yang YB, Liu Y, Dong Y, Zhang ZB, Zhu YP, Feng YJ (2012) Network motifs in the transcriptional regulation network of cervical carcinoma cells respond to EGF. Arch Gynecol Obstet 287(4):771-777
5. Higareda-Almaraz J, Enríquez-Gasca M, Hernández-Ortiz M, Resendis-Antonio O, Encarnación-Guevara S (2011) Proteomic patterns of cervical cancer cell lines, a network perspective. BMC Syst Biol 5:96
6. Ying S-Y, Chang DC, Lin S-L (2008) The microRNA (miRNA): overview of the RNA genes that modulate gene function. Mol Biotechnol 38:257-268
7. Schöniger C, Arenz C (2013) Perspectives in targeting miRNA function. Bioorg Med Chem 21(20):6115-6118
8. Pai P, Rachagani S, Are C, Batra S (2013) Prospects of miRNA-based therapy for pancreatic cancer. Curr Drug Targets 14(10):1101-1109
9. Xue Y, Abou Tayoun AN, Abo KM, Pipas JM, Gordon SR, Gardner TB, Barth RJ Jr, Suriawinata AA, Tsongalis GJ (2013) MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm. Cancer Genet 206(6):217-221
10. Kim JH, Lee JY, Lee KT, Lee JK, Lee KH, Jang K-T, Heo JS, Choi SH, Rhee JC (2010) RGS16 and FosB underexpressed in pancreatic cancer with lymph node metastasis promote tumor progression. Tumor Biol 31:541-548
11. Fu B, Luo M, Lakkur S, Lucito R, Iacobuzio-Donahue CA (2008) Frequent genomic copy number gain and overexpression of GATA-6 in pancreatic carcinoma. Cancer Biol Ther 7:1593-1601
12. Pei H, Li L, Fridley BL, Jenkins GD, Kalari KR, Lingle W, Petersen G, Lou Z, Wang L (2009) FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 16:259-266
13. Lee K-H, Lotterman C, Karikari C, Omura N, Feldmann G, Habbe N, Goggins MG, Mendell JT, Maitra A (2009) Epigenetic silencing of microRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology 9:293-301
14. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4:P3
15. Harris M, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R, Eilbeck K, Lewis S, Marshall B, Mungall C (2004) The gene ontology (GO) database and informatics resource. Nucleic Acids Res 32:D258-D261 (Pubitemid 38081651)
16. Karolchik D, Baertsch R, Diekhans M, Furey TS, Hinrichs A, Lu Y, Roskin KM, Schwartz M, Sugnet CW, Thomas DJ (2003) The UCSC genome browser database. Nucleic Acids Res 31:51-54 (Pubitemid 36150331)
17. Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P, Hatzigeorgiou AG (2009) The database of experimentally supported targets: a functional update of TarBase. Nucleic Acids Res 37:D155-D158
18. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498-2504 (Pubitemid 37428274)
19. Da Wei Huang BTS, Lempicki RA (2008) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57
20. Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37:1-13
21. Lee H-J, Jang M, Kim H, Kwak W, Park W, Hwang JY, Lee C-K, Jang GW, Park MN, Kim H-C (2013) Comparative transcriptome analysis of adipose tissues reveals that ECM-receptor interaction is involved in the depot-specific adipogenesis in cattle. PLoS One 8:e66267
22. Ding D, Lou X, Hua D, Yu W, Li L, Wang J, Gao F, Zhao N, Ren G, Li L (2012) Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach. PLoS Genet 8:e1003065
23. Krupp M, Maass T, Marquardt J, Staib F, Bauer T, König R, Biesterfeld S, Galle P, Tresch A, Teufel A (2011) The functional cancer map: a systems-level synopsis of genetic deregulation in cancer. BMC Med Genomics 4:53
24. Li Z, Gou J, Xu J (2013) Down-regulation of focal adhesion signaling in response to cyclophilin A knockdown in human endometrial cancer cells, implicated by cDNA microarray analysis. Gynecol Oncol 131(1):191-197
25. Liao Q, Kleeff J, Xiao Y, Di Cesare P, Korc M, Zimmermann A, Büchler M, Friess H (2003) COMP is selectively up-regulated in degenerating acinar cells in chronic pancreatitis and in chronic-pancreatitis-like lesions in pancreatic cancer. Scand J Gastroenterol 38:207-215 (Pubitemid 36349934)
26. Zgheib NB, Xiong Y, Marchion DC, Bicaku E, Chon HS, Stickles XB, Sawah EA, Judson PL, Hakam A, Gonzalez-Bosquet J (2012) The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancer. Int J Oncol 41:179-188
27. Kwon O-H, Park J-L, Kim M, Kim J-H, Lee H-C, Kim H-J, Noh S-M, Song K-S, Yoo H-S, Paik S-G (2011) Aberrant up-regulation of LAMB3 and LAMC2 by promoter demethylation in gastric cancer. Biochem Biophys Res Commun 406:539-545
28. Kosanam H, Prassas I, Chrystoja CC, Soleas I, Chan A, Dimitromanolakis A, Blasutig IM, Rückert F, Gruetzmann R, Pilarsky C (2013) LAMC2: a promising new pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues. Mol Cell Proteomics 12(10):2820-2832
29. Greither T, Grochola LF, Udelnow A, Lautenschläger C, Würl P, Taubert H (2010) Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 126:73-80
30. De Nicolo A, Tancredi M, Lombardi G, Flemma CC, Barbuti S, Di Cristofano C, Sobhian B, Bevilacqua G, Drapkin R, Caligo MA (2008) A novel breast cancer-associated BRIP1 (FANCJ/BACH1) germ-line mutation impairs protein stability and function. Clin Cancer Res 14:4672-4680
31. Thompson D, Easton DF (2002) Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94:1358-1365 (Pubitemid 35154140)
32. Detjen K, Farwig K, Welzel M, Wiedenmann B, Rosewicz S (2001) Interferon ̀ inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis. Gut 49:251-262 (Pubitemid 32675120)
33. Bouker KB, Skaar TC, Riggins RB, Harburger DS, Fernandez DR, Zwart A, Wang A, Clarke R (2005) Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis. Carcinogenesis 26:1527-1535 (Pubitemid 41244519)
34. Connett JM, Badri L, Giordano TJ, Connett WC, Doherty GM (2005) Interferon regulatory factor 1 (IRF-1) and IRF-2 expression in breast cancer tissue microarrays. J Interferon Cytokine Res 25:587-594 (Pubitemid 41507814)
35. Cho W (2007) OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 6:60